Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
Sheppard, Mullin, Richter & Hampton LLP advises pharma, biotech, medical device, and digital health clients in matters spanning the entire product lifecycle. With notable FDA regulatory expertise, its work includes counseling, compliance, and due diligence matters. On the IP side, it handles strategic portfolio development and licensing, prosecution, and due diligence. The team is led by New York-based Jeffrey Fessler and Scott Liebman, who focus on corporate transactions and FDA regulatory, compliance, and legal matters, respectively. Jaime Choi joined San Diego’s Del Mar office from Snell & Wilmer LLP, bringing complex patent and disputes expertise. Washington DC-based Kwan-Ho Chung, who arrived from Perkins Coie LLP, focuses on patent prosecution, counseling, and litigation.
L'éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
- 'Jeff Fessler, Nazia Khan and Emily Mastoloni are very knowledgeable and accessible. Jeff always responds quickly to questions and has a great business sense.'
Clients clés
- Pacira Biosciences Inc.
- Gilead Sciences, Inc.
Points forts
- Representing Pacira Biosciences in federal Lanham Act cases against three compounding pharmacies that produce 'drug cocktails' marketed as alternatives to Exparel, Pacira’s pain medication.
- Represents Gilead Sciences, Inc. in its patent portfolio, including its role as outside U.S. patent counsel for breakthrough Hepatitis C (HCV) drugs and several oncology assets in preclinical and clinical development.